2025-10-09 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc. (UNH) based on the provided data, formatted as requested.

## UnitedHealth Group Inc. (UNH) Analysis

**Company Overview:** UnitedHealth Group Inc. is a diversified healthcare company providing health benefits and services.

### 1. Performance vs. S&P 500 (VOO)

*   **UNH Cumulative Return:** -13.64%
*   **VOO Cumulative Return:** 99.62%
*   **Absolute Divergence:** -114.4% (UNH is lagging VOO)
*   **Relative Divergence:** 9.8 (Indicates UNH's divergence is near the lower end of its historical range compared to VOO)

**Analysis:** UNH has significantly underperformed the S&P 500. The large negative divergence indicates substantial underperformance relative to the market. The relative divergence suggests this underperformance is near the worst it has been historically.

**Alpha/Beta Analysis (Historical Rolling 3-Year Periods):**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
|------------|---------|---------|---------|-------|--------|
| 2015-2017  | 58.0%   | 66.4%   | 30.0%   | 0.1   | 199.7  |
| 2016-2018  | 41.0%   | 70.4%   | 26.0%   | 0.1   | 225.6  |
| 2017-2019  | 36.0%   | 73.8%   | 14.0%   | 0.2   | 266.2  |
| 2018-2020  | -43.0%  | 81.2%   | -67.0%  | 0.5   | 317.6  |
| 2019-2021  | 16.0%   | 81.2%   | -30.0%  | 1.5   | 454.8  |
| 2020-2022  | -1.0%   | 81.2%   | 0.0%    | 1.5   | 480.2  |
| 2021-2023  | 24.0%   | 80.8%   | 23.0%   | 0.4   | 476.8  |
| 2022-2024  | -27.0%  | 78.8%   | -47.0%  | 0.3   | 458.1  |
| 2023-2025  | -56.0%  | 78.8%   | -120.0% | 1.3   | 335.0  |

*   **CAGR:** Varies significantly, with recent periods showing negative growth.
*   **MDD:** High Maximum Drawdown values across all periods, indicating significant volatility.
*   **Alpha:** Consistently positive in earlier periods but has turned negative, indicating underperformance relative to the market on a risk-adjusted basis.
*   **Beta:** Low Beta values in early periods indicate less sensitivity to market movements, but recent Beta values are closer to 1 or higher, suggesting increased market correlation.

**Analysis:** The Alpha/Beta analysis reveals a concerning trend. UNH's performance has deteriorated in recent years. The negative Alpha values indicate underperformance compared to its expected return based on its Beta, and the high MDD values highlight significant downside risk.

### 2. Recent Stock Price Movements

*   **Current Price:** \$369.92
*   **Previous Close:** \$363.66
*   **Change:** \$1.72 (Upward Movement)
*   **5-Day Moving Average:** \$361.25
*   **20-Day Moving Average:** \$349.26
*   **60-Day Moving Average:** \$307.63

**Analysis:** UNH's price is above its 5, 20, and 60-day moving averages, indicating a short-term upward trend. The recent price increase (\$1.72) suggests positive momentum.

### 3. Technical Indicators & Outlook

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 81.88 (Overbought)
*   **PPO:** 0.041
*   **Hybrid Signal:** Cash_0%_Buy 100% of cash (2 shares - Very Safe - MRI:0.90)
*   **Recent (20-day) Relative Divergence Change:** 1.5 (+), suggesting short-term improvement.
*   **Expected Return:** -126.1% (Long-term underperformance vs. S&P 500)

**Analysis:**

*   **MRI:** Despite recent underperformance, the MRI suggests that from a market perspective, the stock is in a recommended investment range.
*   **RSI:** The high RSI indicates the stock is overbought and may experience a pullback.
*   **PPO:** The PPO is positive, confirming the short-term upward trend.
*   **Hybrid Signal:** The hybrid signal suggests a strong buy.
*   **Relative Divergence Change:** Indicates some recent recovery relative to the comparison index.
*   **Expected Return:** The negative expected return signals significant underperformance relative to the S&P 500 over a longer-term investment horizon.

### 4. Recent News & Analyst Opinions

**News Headlines (October 8, 2025):**

*   Analysts are raising price targets for UNH.
*   Earnings preview indicates investor interest in the upcoming quarterly results.

**Analyst Consensus:**

*   **Consensus:** Buy (Mean: 1.96)
*   **Target Price:** Avg: \$352.21, High: \$626.00, Low: \$198.00
*   **Recent Rating Changes:** Not specified (Indicates no recent changes in provided data)

**Analysis:** Recent analyst activity is positive, with multiple firms raising their price targets. The overall consensus is a "Buy," suggesting confidence in the company's future prospects.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출           |
|------------|------|----------------|
| 2025-08-11 | 3.76 | 111.62 B\$    |
| 2025-05-07 | 6.9  | 109.58 B\$    |
| 2024-11-04 | 6.56 | 100.82 B\$    |
| 2024-08-09 | 4.58 | 98.86 B\$    |
| 2025-08-11 | 4.58 | 98.86 B\$    |

**Analysis:** Revenue has been generally increasing, but EPS has fluctuated.

### 6. Financial Information

| Quarter    | Revenue     | Profit Margin |
|------------|-------------|---------------|
| 2025-06-30 | \$111.62B   | 17.93%        |
| 2025-03-31 | \$109.58B   | 21.70%        |
| 2024-12-31 | \$100.81B   | 21.14%        |
| 2024-09-30 | \$100.82B   | 22.84%        |
| 2024-06-30 | \$98.86B    | 22.31%        |

| Quarter    | Equity    | ROE    |
|------------|-----------|--------|
| 2025-06-30 | \$94.72B  | 3.60%  |
| 2025-03-31 | \$95.04B  | 6.62%  |
| 2024-12-31 | \$92.66B  | 5.98%  |
| 2024-09-30 | \$94.53B  | 6.41%  |
| 2024-06-30 | \$89.36B  | 4.72%  |

**Analysis:**

*   **Revenue:** Consistent growth in revenue.
*   **Profit Margin:** Fluctuating profit margins, with a recent dip.
*   **Equity:** Relatively stable equity.
*   **ROE:** Volatile ROE, with a decrease in the most recent quarter.

### 7. Overall Conclusion

Based on the provided data, UnitedHealth Group (UNH) presents a mixed picture:

*   **Negative Factors:** Significant underperformance compared to the S&P 500, negative expected return over the long term, and fluctuating profitability metrics.
*   **Positive Factors:** Recent positive price momentum, positive analyst ratings and price target revisions, increasing revenue, and a high Market Risk Indicator suggesting overall market confidence.

**Investment Recommendation:**

While recent analyst upgrades and positive price action are encouraging, the substantial underperformance relative to the market and the negative expected return are major concerns. The high RSI suggests a potential pullback. A cautious approach is warranted. Investors should carefully weigh the positive analyst sentiment against the concerning performance metrics and consider their risk tolerance before investing.

**Disclaimer:** This analysis is based solely on the provided data and does not constitute financial advice. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
